Dapeng Li Selected Research

Dapeng Li Research Topics

Disease

48	Neoplasms (Cancer) 07/2022 - 05/2006
19	Infections 02/2022 - 02/2005
11	Inflammation (Inflammations) 03/2022 - 01/2010
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
11	Body Weight (Weight, Body) 01/2022 - 06/2007
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 05/2014
7	COVID-19 01/2022 - 01/2021
7	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2007
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2015
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2017
5	Virus Diseases (Viral Diseases) 03/2021 - 03/2016
5	Carcinoma (Carcinomatosis) 05/2017 - 10/2009
4	Weight Gain 01/2022 - 09/2017
4	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 04/2018
4	Intervertebral Disc Degeneration 01/2018 - 01/2014
3	Neuroinflammatory Diseases 03/2022 - 10/2020
3	Obesity 01/2022 - 10/2019
3	Adenocarcinoma of Lung 01/2022 - 06/2020
3	Carcinogenesis 01/2022 - 01/2012
3	Pain (Aches) 03/2021 - 09/2015
3	Reinfection 01/2021 - 01/2017
3	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 12/2017
3	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 02/2005
3	Fibrosis (Cirrhosis) 01/2020 - 12/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2015 - 10/2009
2	Cognitive Dysfunction 03/2022 - 10/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 10/2020
2	Non-alcoholic Fatty Liver Disease 11/2021 - 10/2019
2	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2012
2	Hypertrophy 08/2021 - 01/2015
2	Breakthrough Infections 05/2021 - 01/2021
2	Edema (Dropsy) 02/2021 - 01/2021
2	Pneumonia (Pneumonitis) 02/2021 - 01/2021
2	Asthma (Bronchial Asthma) 01/2021 - 01/2018
2	Hypertension (High Blood Pressure) 11/2020 - 10/2020
2	Overweight 10/2020 - 01/2018
2	Lymphatic Metastasis 01/2020 - 06/2014
2	Papillary Thyroid Cancer 01/2020 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 02/2005
2	Zika Virus Infection 10/2019 - 01/2018
2	Wounds and Injuries (Trauma) 11/2018 - 01/2018
2	Liver Neoplasms (Liver Cancer) 01/2018 - 12/2010

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2005
15	VaccinesIBA 02/2022 - 07/2014
11	Messenger RNA (mRNA)IBA 08/2021 - 01/2013
9	Pharmaceutical PreparationsIBA 03/2021 - 12/2007
8	Biomarkers (Surrogate Marker)IBA 10/2022 - 09/2019
8	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2011
7	Neutralizing AntibodiesIBA 02/2022 - 04/2013
6	AntibodiesIBA 01/2022 - 01/2019
5	AntioxidantsIBA 03/2022 - 04/2008
5	Sirtuin 1IBA 03/2022 - 04/2018
5	CytokinesIBA 08/2021 - 08/2012
5	Biological ProductsIBA 01/2020 - 12/2007
5	MicrocystinsIBA 10/2011 - 06/2007
4	EnzymesIBA 05/2022 - 04/2008
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2015
4	PolyphenolsIBA 01/2022 - 09/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2005
4	Interleukin-6 (Interleukin 6)IBA 11/2021 - 08/2012
4	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2017
3	CrizotinibIBA 01/2022 - 06/2020
3	NitrogenIBA 01/2022 - 06/2021
3	TeaIBA 01/2022 - 09/2017
3	Cadmium Chloride (Cadmium Dichloride)IBA 12/2021 - 10/2020
3	Therapeutic UsesIBA 11/2021 - 01/2018
3	Peptides (Polypeptides)IBA 01/2020 - 05/2006
3	NitritesIBA 11/2018 - 09/2017
3	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2010
2	Cadherins (E-Cadherin)IBA 05/2022 - 01/2013
2	DH1047IBA 01/2022 - 04/2021
2	Saline SolutionIBA 01/2022 - 09/2015
2	FlavonoidsIBA 01/2022 - 02/2021
2	CreatinineIBA 01/2022 - 08/2021
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 08/2021
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	Histones (Histone)IBA 01/2022 - 05/2013
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2022 - 11/2021
2	QuercetinIBA 01/2022 - 01/2019
2	SeleniumIBA 08/2021 - 09/2017
2	Tyrosine Kinase InhibitorsIBA 07/2021 - 01/2020
2	osimertinibIBA 07/2021 - 06/2020
2	remdesivirIBA 04/2021 - 01/2021
2	Monoclonal AntibodiesIBA 04/2021 - 01/2021
2	Blocking AntibodiesIBA 02/2021 - 01/2021
2	Fc Receptors (Fc Receptor)IBA 02/2021 - 01/2021
2	Celecoxib (Celebrex)FDA Link 11/2020 - 05/2017
2	CadmiumIBA 10/2020 - 07/2020
2	EstersIBA 12/2019 - 09/2019
2	Broadly Neutralizing AntibodiesIBA 10/2019 - 01/2017
2	Carcinoembryonic AntigenIBA 01/2019 - 10/2009
2	Polymethyl Methacrylate (Sol)IBA 09/2018 - 06/2016
2	HydrogelsIBA 09/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 04/2018 - 10/2017

Therapy/Procedure

13	Therapeutics 07/2022 - 05/2014
9	Drug Therapy (Chemotherapy) 01/2022 - 07/2016
5	Immunotherapy 01/2022 - 01/2010
4	Radiotherapy 07/2022 - 07/2016
3	Chemoradiotherapy 01/2022 - 05/2014
2	Injections 07/2021 - 09/2015